Form 8-K - Current report:
SEC Accession No. 0001104659-19-064172
Filing Date
2019-11-14
Accepted
2019-11-14 16:06:57
Documents
3
Period of Report
2019-11-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1922709d4_8k.htm 8-K 19428
2 EXHIBIT 5.1 tm1922709d4_ex5-1.htm EX-5.1 17306
3 GRAPHIC logo.gif GRAPHIC 3467
  Complete submission text file 0001104659-19-064172.txt   42667
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 191220091
SIC: 2834 Pharmaceutical Preparations